Advertisement
For obese women

Levonorgestrel IUD Potentially Cost-Effective in Obese Women

0
Intrauterine device is potentially cost-effective for prevention of deaths from endometrial cancer
Many female adolescent patients with acute leukemia and emergency room visits have low rates of pregnancy screening before teratogenic exposures

Pregnancy Screens Lacking for Teens With Leukemia

0
Low rates for teens with acute leukemia and ER visits before teratogenic exposures
Pevonedistat

Experimental Drug Shows Promise in Melanoma

0
Pevonedistat was effective for inhibiting proliferation of melanoma cell lines in vitro
People who care for loved ones with cancer face more challenges than those who care for those with other health problems

Caregivers for Cancer Patients Face Unique Challenges

0
Survey results suggest more support is warranted
Starting palliative care shortly after an incurable cancer diagnosis helps patients cope and improves their quality of life

Early Palliative Care Ups QOL for Terminal Cancer Patients

0
Early care also increases chances of having end-of-life discussions
Umbilical cord blood may work as well as current alternatives for adults and children with leukemia -- or even better in some cases

Treating Leukemia With Cord-Blood Transplant Looks Promising

0
Donors and recipients don't need to be a perfect match, researcher says
Dexrazoxane can prevent anthracycline-induced cardiotoxicity and should be used for cardioprotection in children and young adults

Dexrazoxane Prevents Chemo-Induced Cardiotoxicity

0
Dexrazoxane beneficial for preventing anthracycline-induced cardiotoxicity in children, young adults
Immunotherapy with CD19 chimeric antigen receptor-modified T cells in a defined CD4+/CD8+ ratio can lead to improved disease response and overall and progression-free survival

Remission Up With T Cell Therapy for Non-Hodgkin’s Lymphoma

0
Researchers identify treatment characteristics that correlate with therapeutic response, toxicity
Prostate-specific antigen failure is associated with increased risk of all-cause mortality for men with intermediate- or high-risk prostate cancer with no or minimal comorbidity

PSA Failure Predicts Death in Men With No, Minimal Comorbidity

0
Findings among men with localized intermediate- and high-risk prostate cancer
Obesity may increase survival for patients with metastatic renal cell carcinoma

Obesity May Up Survival in Metastatic Renal Cell Carcinoma

0
Obese/overweight patients survived 25.6 months, compared to 17.1 months for normal-weight patients